HTBZ

Kirk A. Frey · Phase 1 active Small molecule

At a glance

Generic name	HTBZ
Sponsor	Kirk A. Frey
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Alternatives for Reducing Chorea in Huntington Disease (PHASE3)
(+)-Alpha-Dihydrotetrabenazine Phase I (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

HTBZ CI brief — competitive landscape report
HTBZ updates RSS · CI watch RSS
Kirk A. Frey portfolio CI